T he US Food and Drug Administration approved the first nasal spray epinephrine drug for severe allergic reactions known as ...

"Anaphylaxis is life-threatening and some people, particularly children, may delay or avoid treatment due to fear of ...

The neffyinSchools program from ARS Pharma will provide eligible public and private K-12 schools in the United States with ...

Dr Ruchi Gupta shares her excitement about updates on prevention and management, particularly for anaphylaxis, angioedema, ...

Nasus Pharma Ltd. ("Nasus Pharma" or the "Company"), a clinical-stage biopharmaceutical company focused on developing ...

44% of children with anaphylaxis received epinephrine before visiting the ED. There was no difference in admission to hospital wards. Children who used epinephrine were less likely to receive ...

Administer epinephrine to patients with systemic manifestations of anaphylaxis. When there is mild cutaneous reaction, an antihistamine alone may be sufficient, thus the potential adverse effects ...

(Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from allergic reactions that could lead to anaphylaxis, today announced ...

at the onset of an allergic reaction, as compared to currently available epinephrine self-injectors. FMXIN002 uses APTAR Nasal Unidose Powder device – an intuitive and easy-to-use device with ...

(Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from allergic reactions that could lead to anaphylaxis, today ...

While anaphylaxis can progress rapidly and occur at any time, many states must update their legislation to include nasal delivery in local epinephrine stocking and indemnification laws ...